Unresectable Stage III or Stage IV Melanoma
2 clinical trials · Condition
◉ Watch Unresectable Stage III or Stage IV Melanoma
| Record | Firm | Date |
|---|---|---|
| A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma (NCT02413827) | Celldex Therapeutics | 2015-04-01 |
| A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma (NCT00412828) | CuraGen Corporation | 2006-06-01 |
Track Unresectable Stage III or Stage IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.